Cargando…
Unquantifiably low aldosterone concentrations are prevalent in hospitalised COVID-19 patients but may not be revealed by chemiluminescent immunoassay
OBJECTIVE: Previous studies have reported conflicting findings regarding aldosterone levels in patients hospitalised with COVID-19. We therefore used the gold-standard technique of liquid chromatography–tandem mass spectrometry (LCMSMS) to address this uncertainty. DESIGN: All patients admitted to C...
Autores principales: | Wiegand, Martin, Halsall, David J, Cowan, Sarah L, Taylor, Kevin, Goudie, Robert J B, Preller, Jacobus, Gurnell, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578067/ https://www.ncbi.nlm.nih.gov/pubmed/36006845 http://dx.doi.org/10.1530/EC-22-0190 |
Ejemplares similares
-
Novel chemiluminescent immunoassay to measure plasma aldosterone and plasma active renin concentrations for the diagnosis of primary aldosteronism
por: Teruyama, Kyoko, et al.
Publicado: (2021) -
Validation of The 4C Deterioration Model for COVID-19 in a UK Teaching Hospital During Wave 2
por: Cowan, Sarah L., et al.
Publicado: (2021) -
Feasibility of Screening Primary Aldosteronism by Aldosterone-to-Direct Renin Concentration Ratio Derived from Chemiluminescent Immunoassay Measurement: Diagnostic Accuracy and Cutoff Value
por: Li, Tianqi, et al.
Publicado: (2019) -
Carotid plaque ulceration: unquantified predictor of stroke
por: Smith, Luke C, et al.
Publicado: (2023) -
Development of a New Chemiluminescent Enzyme Immunoassay Using a Two-Step Sandwich Method for Measuring Aldosterone Concentrations
por: Ozeki, Yoshinori, et al.
Publicado: (2021)